Over the past 3 days,
more than 3700 hospital pharmacists from over 60 different countries met in
Barcelona, Spain for the annual congress of the European Association of
Hospital Pharmacists (EAHP).
The Scientific
Programme centred this year around the theme “Personalised Hospital Pharmacy
– meeting the needs of every patient”. On each of the 3 fully packed days,
congress attendees had the possibility to attend a number of seminars,
workshops and Synergy Satellites. The latter addressed developments in the
field of biosimilars, anticoagulation as well as the Falsified Medicines
Directive (FMD) and Brexit. Keynotes were delivered on the topic of OMICS,
clinical human factors and health inequalities.
|
EAHP’s Statement
Implementation team welcomed numerous individuals to talk about the European
Statements of Hospital Pharmacy, the self-assessment tool as well as the
Statement Implementation Learning Collaborative Centres (SILCC) programme. In
addition, the team shared information published in EAHP’s 2018 Medicines
Shortages Report which outlines the seriousness of the growing problem of
medicines shortages in the hospital sector.
EAHP's poster walk, a
unique Congress feature, brought together participants and poster authors to
discuss the latest research innovations. The Scientific Committee awarded the
1st prize for poster submissions to Meshal Alshakrah for the abstract and
poster titled ‘Determining the necessary components of a pharmaceutical care
complexity screening tool: an e-delphi study'. The 2019 Good Practice
Initiative (GIP) award went to Charlotte Olesen for her work on "Using
an electronic algorithm to identify the most relevant patients for medication
review".
EAHP would like to
thank its Platinum Partners, Amgen and Bayer, its Gold Partner, Pfizer and
its Corporate Partners, Omnicell and MSD, for their support.
EAHP is already
looking forward to celebrating the 25th anniversary of
its congress in 2020. For this occasion the Association will be returning to
Gothenburg, Sweden from 25th to 27th March
2020.
|
No comments:
Post a Comment